Gabapentin and Risk of Pancreatic Cancer and Renal Cancer
The focus of this clinical trial was evaluate how exposure to gabapentin increased a patient's risk of developing pancreatic or renal cancers.
Study Type: Observational
Age/Gender Requirements: Not listed
Sponsor: GlaxoSmithKline
Purpose: The main objective of this clinical trial was "to determine whether exposure to gabapentin is associated with an increased risk of dveloping pancreatic cancer or renal cancer in the United Kingdom (UK) General Practice Research Database (GPRD)."
ClinicalTrials.gove identifier: NCT01138124
Click here to access additional information about the clinical trial.
Recent Videos
Related Content
